Welcome, Guest. Please login or register.
November 24, 2024, 07:50:40 am

Login with username, password and session length


Members
Stats
  • Total Posts: 55133
  • Total Topics: 4851
  • Online Today: 222
  • Online Ever: 3061
  • (September 25, 2024, 11:40:40 pm)
Users Online
Users: 0
Guests: 205
Total: 205

Welcome

Welcome to the Hep Forums, a round-the-clock discussion area for people who have Fatty Liver Disease, Hepatitis B, C or a co-infection, their friends and family and others with questions about hepatitis and liver health. Check in frequently to read what others have to say, post your comments, and hopefully learn more about how you can reach your own health goals.

Privacy Warning: Please realize that these forums are open to all, and are fully searchable via Google and other search engines. If this concerns you, then do not use a username or avatar that are self-identifying in any way. We do not allow the deletion of anything you post in these forums, so think before you post.
  • The information shared in these forums, by moderators and members, is designed to complement, not replace, the relationship between an individual and his/her own physician.
  • All members of these forums are, by default, not considered to be licensed medical providers. If otherwise, users must clearly define themselves as such.
  • Product advertisement (including links); banners; and clinical trial, study or survey participation—is strictly prohibited by forums members unless permission has been secured from the Hep Forum Moderators.
Finished Reading This? You can collapse this or any other box on this page by clicking the symbol in each box.

Author Topic: Gilead’s Hep C Cure Was Initially Pitched to Be Half the Price  (Read 8625 times)

0 Members and 1 Guest are viewing this topic.

Offline Hep Editors

  • Member
  • Posts: 784
    • Hep Mag
Public documents from 2011 show that Pharmasset—the original developer of Sovaldi— estimated a price of $36,000 for the next-generation treatment. However, the drug’s cost was adjusted after Gilead bought out the smaller pharmaceutical company.

Today, analysts say curing the deadly liver disease with Sovaldi and other meds could cost around $100,000 per patient at current pricing.

Read more: http://www.hepmag.com/articles/sovaldi_initially_pitched_at_half_cost_2831_26015.shtml

Offline willie g

  • Member
  • Posts: 427
  • geno 1 25million etc. s/o for treatment
Re: Gilead’s Hep C Cure Was Initially Pitched to Be Half the Price
« Reply #1 on: August 08, 2014, 03:21:08 am »
it is all about the cash for company's, the developers were probably duped at the closing  lol  seriously though how did the developers respond to the substantial increase even though it was out of their hands at that point?  it sure made it harder to get from insurance. is that why they had coupons etc. and the developing of the drug is done with our tax dollars right? just wondering, thanks  willie g

Offline Dharn55

  • Member
  • Posts: 12
Re: Gilead’s Hep C Cure Was Initially Pitched to Be Half the Price
« Reply #2 on: August 08, 2014, 07:45:39 am »
Gilead paid $11 billion for Pharmasett, which was a 89% premium over its "market value" at that time. So the owners and executives at Pharmasett did pretty good. Somewhere there is a huge amount of money being made on Sovaldi. In the first 6 months of 2014 the sales of Sovaldi were reported to be $5.8 billion, so Sovaldi has recouped over 50% of the acquisition price! and it also acquired other drugs and products in the Pharmasett portfolio. Of course there have been other costs to Gilead in the process of getting the FDA approval, etc. however they stand to make many multiples of the investment they have made.

Offline willie g

  • Member
  • Posts: 427
  • geno 1 25million etc. s/o for treatment
Re: Gilead’s Hep C Cure Was Initially Pitched to Be Half the Price
« Reply #3 on: August 11, 2014, 02:49:32 am »
thankyou, looks like everybody is happy with thier cash exchange,  i knew i was always in the wrong business lol  at least there picking up the tab for folks who cant pay for it but in the end they make out bigger and they get to see how thede drugs are really working  wille g

 


© 2024 Smart + Strong. All Rights Reserved.   terms of use and your privacy
Smart + Strong® is a registered trademark of CDM Publishing, LLC.